|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nutrients in the intestine initiate changes in secretory and motor function of the gastrointestinal (GI) tract. The nature of the 'sensors' in the intestinal wall is not well characterized. Intestinal lipid stimulates the release of cholecystokinin (CCK) from mucosal entero-endocrine cells, and it is proposed that CCK activates CCK A receptors on vagal afferent nerve terminals. There is evidence that chylomicron components are involved in this lipid transduction pathway. The aim of the present study was to determine (1) the pathway mediating reflex inhibition of gastric motility and (2) activation of duodenal vagal afferents in response to chylomicrons. Mesenteric lymph was obtained from awake rats fitted with lymph fistulas during intestinal perfusion of lipid (Intralipid, 170 µmol h-1, chylous lymph) or a dextrose and/or electrolyte solution (control lymph). Inhibition of gastric motility was measured manometrically in urethane-anaesthetized recipient rats in response to intra-arterial injection of lymph close to the upper GI tract. Chylous lymph was significantly more potent than control lymph in inhibiting gastric motility. Functional vagal deafferentation by perineural capsaicin or CCK A receptor antagonist (devazepide, 1 mg kg-1, I.V.) significantly reduced chylous lymph-induced inhibition of gastric motility. The discharge of duodenal vagal afferent fibres was recorded from the dorsal abdominal vagus nerve in an in vitro preparation of the duodenum. Duodenal vagal afferent nerve fibre discharge was significantly increased by close-arterial injection of CCK (1-100 pmol) in 43 of 83 units tested. The discharge of 88 % of CCK-responsive fibres was increased by close-arterial injection of chylous lymph; devazepide (100 µg, I.A.) abolished the afferent response to chylous lymph in 83 % of these units. These data suggest that in the intestinal mucosa, chylomicrons or their products release endogenous CCK which activates CCK A receptors on vagal afferent nerve fibre terminals, which in turn initiate a vago-vagal reflex inhibition of gastric motor function.
This article has been cited by other articles:
![]() |
S. J. Pandol Integrated Response to a Meal JPEN J Parenter Enteral Nutr, September 1, 2008; 32(5): 564 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Whited, P. Tso, and H. E. Raybould Involvement of Apolipoprotein A-IV and Cholecystokinin1 Receptors in Exogenous Peptide YY3 36-Induced Stimulation of Intestinal Feedback Endocrinology, October 1, 2007; 148(10): 4695 - 4703. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Adelson, H. P. Kosoyan, Y. Wang, J. Z. Steinberg, and Y. Tache Gastric Vagal Efferent Inhibition Evoked by Intravenous CRF Is Unrelated to Simultaneously Recorded Vagal Afferent Activity in Urethane-Anesthetized Rats J Neurophysiol, April 1, 2007; 97(4): 3004 - 3014. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sternini Taste Receptors in the Gastrointestinal Tract. IV. Functional implications of bitter taste receptors in gastrointestinal chemosensing Am J Physiol Gastrointest Liver Physiol, February 1, 2007; 292(2): G457 - G461. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Alvarez, S. Ibiza, C. Hernandez, A. Alvarez-Barrientos, J. V. Esplugues, and S. Calatayud Gastrin induces leukocyte-endothelial cell interactions in vivo and contributes to the inflammation caused by Helicobacter pylori FASEB J, November 1, 2006; 20(13): 2396 - 2398. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Freeman, D. Bohan, N. Darcel, and H. E. Raybould Luminal glucose sensing in the rat intestine has characteristics of a sodium-glucose cotransporter Am J Physiol Gastrointest Liver Physiol, September 1, 2006; 291(3): G439 - G445. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dufresne, C. Seva, and D. Fourmy Cholecystokinin and gastrin receptors. Physiol Rev, July 1, 2006; 86(3): 805 - 847. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Sartor, A. Shulkes, and A. J. M. Verberne An enteric signal regulates putative gastrointestinal presympathetic vasomotor neurons in rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R625 - R633. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Whited, D. Lu, P. Tso, K. C. Kent Lloyd, and H. E. Raybould Apolipoprotein A-IV is involved in detection of lipid in the rat intestine J. Physiol., December 15, 2005; 569(3): 949 - 958. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Darcel, A. P. Liou, D. Tome, and H. E. Raybould Activation of Vagal Afferents in the Rat Duodenum by Protein Digests Requires PepT1 J. Nutr., June 1, 2005; 135(6): 1491 - 1495. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Feltrin, T. J. Little, J. H. Meyer, M. Horowitz, A. J. P. M. Smout, J. Wishart, A. N. Pilichiewicz, T. Rades, I. M. Chapman, and C. Feinle-Bisset Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R524 - R533. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Glatzle, N. Darcel, A. J. Rechs, T. J. Kalogeris, P. Tso, and H. E. Raybould Apolipoprotein A-IV stimulates duodenal vagal afferent activity to inhibit gastric motility via a CCK1 pathway Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R354 - R359. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Tso, W. Sun, and M. Liu Gastrointestinal Satiety Signals IV. Apolipoprotein A-IV Am J Physiol Gastrointest Liver Physiol, June 1, 2004; 286(6): G885 - G890. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |